APA

Naarding P., van Grevenstein M. & Beekman A. T. F. (20110126). Benefit-risk analysis for the clinician: 'primum non nocere' revisited--the case for antipsychotics in the treatment of behavioural disturbances in dementia. : International journal of geriatric psychiatry.

Chicago

Naarding P, van Grevenstein M and Beekman A T F. 20110126. Benefit-risk analysis for the clinician: 'primum non nocere' revisited--the case for antipsychotics in the treatment of behavioural disturbances in dementia. : International journal of geriatric psychiatry.

Harvard

Naarding P., van Grevenstein M. and Beekman A. T. F. (20110126). Benefit-risk analysis for the clinician: 'primum non nocere' revisited--the case for antipsychotics in the treatment of behavioural disturbances in dementia. : International journal of geriatric psychiatry.

MLA

Naarding P, van Grevenstein M and Beekman A T F. Benefit-risk analysis for the clinician: 'primum non nocere' revisited--the case for antipsychotics in the treatment of behavioural disturbances in dementia. : International journal of geriatric psychiatry. 20110126.